Clinical Trials List
2021-06-20 - 2025-12-31
Phase I
Recruiting2
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Liang-Chih Liu Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Junping Shiau Shiau Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- 高理鈞 Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
- 高捷妮 Division of General Surgery
- 甘蓉瑜 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ling-Ming Tseng Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
- 姜乃榕 Division of Hematology & Oncology
- Chi-Cheng Huang Division of General Surgery
- 賴亦貞 Division of Radiology
- Chun-Yu Liu Division of General Internal Medicine
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
200 participants
